Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
This phase I/II trial studies the best dose of M3814 when given together with radium-223 dichloride or with radium-223 dichloride and avelumab and to see how well they work in treating patients with castrate-resistant prostate cancer that had spread to other places in the body (metastatic). M3814 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Radioactive drugs, such as radium-223 dichloride, may carry radiation directly to tumor cells and not harm norm
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this prostate cancer clinical trial in Los Angeles, CA
If you're searching for prostate cancer treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.